Literature DB >> 11127422

Contingent reinforcement of marijuana abstinence among individuals with serious mental illness: a feasibility study.

S C Sigmon1, S Steingard, G J Badger, S L Anthony, S T Higgins.   

Abstract

The feasibility of using monetary incentives to promote abstinence from marijuana use among individuals with serious mental illness was examined by using a within-subjects experimental design. Participants were 18 adults with schizophrenia or other serious mental illness who reported regular marijuana use. During 2 baseline conditions, participants received payment for submitting urine specimens independent of urinalysis results. During 3 incentive conditions, participants received varying amounts of money if urinalysis results were negative for recent marijuana use. The number of marijuana-negative specimens obtained was significantly greater during incentive than baseline conditions. These results provide evidence that marijuana use among at least some mentally ill individuals is sensitive to contingent reinforcement and support the potential feasibility of using contingency-management interventions to reduce substance abuse among the mentally ill.

Entities:  

Mesh:

Year:  2000        PMID: 11127422     DOI: 10.1037//1064-1297.8.4.509

Source DB:  PubMed          Journal:  Exp Clin Psychopharmacol        ISSN: 1064-1297            Impact factor:   3.157


  24 in total

Review 1.  State of the art treatments for cannabis dependence.

Authors:  Itai Danovitch; David A Gorelick
Journal:  Psychiatr Clin North Am       Date:  2012-04-10

Review 2.  Treatment of substance use disorders in schizophrenia: a unifying neurobiological mechanism?

Authors:  Robert M Roth; Mary F Brunette; Alan I Green
Journal:  Curr Psychiatry Rep       Date:  2005-08       Impact factor: 5.285

3.  Cannabis withdrawal in chronic cannabis users with schizophrenia.

Authors:  Douglas L Boggs; Deanna L Kelly; Fang Liu; Jared A Linthicum; Hailey Turner; Jennifer R Schroeder; Robert P McMahon; David A Gorelick
Journal:  J Psychiatr Res       Date:  2012-11-10       Impact factor: 4.791

Review 4.  Using incentives to reduce substance use and other health risk behaviors among people with serious mental illness.

Authors:  Jennifer W Tidey
Journal:  Prev Med       Date:  2011-12-09       Impact factor: 4.018

5.  Better quality of life in patients offered financial incentives for taking anti-psychotic medication: Linked to improved adherence or more money?

Authors:  Katherine Moran; Stefan Priebe
Journal:  Qual Life Res       Date:  2016-02-05       Impact factor: 4.147

Review 6.  Treatment of the depressed alcoholic patient.

Authors:  Jeffrey J DeVido; Roger D Weiss
Journal:  Curr Psychiatry Rep       Date:  2012-12       Impact factor: 5.285

7.  Duration effects in contingency management treatment of methamphetamine disorders.

Authors:  John M Roll; Joy Chudzynski; Jennifer M Cameron; Donelle N Howell; Sterling McPherson
Journal:  Addict Behav       Date:  2013-04-03       Impact factor: 3.913

8.  Relief of cannabis withdrawal symptoms and cannabis quitting strategies in people with schizophrenia.

Authors:  Maju Mathew Koola; Douglas Lee Boggs; Deanna Lynn Kelly; Fang Liu; Jared Allen Linthicum; Hailey Elaine Turner; Robert Patrick McMahon; David Alan Gorelick
Journal:  Psychiatry Res       Date:  2013-08-20       Impact factor: 3.222

9.  Contingency management for cocaine treatment: cash vs. vouchers.

Authors:  David S Festinger; Karen L Dugosh; Kimberly C Kirby; Brittany L Seymour
Journal:  J Subst Abuse Treat       Date:  2014-03-06

10.  Financial incentives to improve adherence to anti-psychotic maintenance medication in non-adherent patients - a cluster randomised controlled trial (FIAT).

Authors:  Stefan Priebe; Alexandra Burton; Deborah Ashby; Richard Ashcroft; Tom Burns; Anthony David; Sandra Eldridge; Mike Firn; Martin Knapp; Rose McCabe
Journal:  BMC Psychiatry       Date:  2009-09-28       Impact factor: 3.630

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.